Patent · US Active

αvβ6 peptide ligands and their uses

US9650416B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

Cancer Research Technology Limited · GB

Inventors

Mark J. Howard · Ashford, GB
Danielle Dicara · South San Francisco, US
John Marshall · London, GB

Key dates

Filing date	Dec 11, 2014
Grant date	May 16, 2017
Priority date	—
Expiry date	Dec 11, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

AVβ6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AVβ6 mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.